Cargando…

Anti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin

BACKGROUND: COVID-19 vaccines have been associated with a rare thrombotic and thrombocytopenic reaction, Vaccine-induced immune thrombotic thrombocytopenia (VITT) characterized by platelet-activating anti-PF4 antibodies. This study sought to assess clonality of VITT antibodies and evaluate their cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, B, Kanack, A, Bayas, A, George, G, Abou-Ismail, MY, Kohlhagen, M, Christ, M, Naumann, M, Moser, K, Smock, K, Grazioli, A, Murray, D, Padmanabhan, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491860/ https://www.ncbi.nlm.nih.gov/pubmed/34611669 http://dx.doi.org/10.1101/2021.09.23.21263047

Ejemplares similares

Monoclonal and Oligoclonal Anti-PF4 Antibodies Mediate VITT
por: Singh, Bandana, et al.
Publicado: (2021)

Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT
por: Kanack, Adam J., et al.
Publicado: (2022)

Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT
por: Abou-Ismail, Mouhamed Yazan, et al.
Publicado: (2022)

Persistence of Ad26.COV2.S‐associated vaccine‐induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies
por: Kanack, Adam J., et al.
Publicado: (2022)

Heparin or nonheparin anticoagulants for VITT
por: Arnold, Donald M.
Publicado: (2022)

Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy
por: Greinacher, Andreas, et al.
Publicado: (2021)

Epidemiology of VITT
por: Pai, Menaka
Publicado: (2022)

Longitudinal Aspects of VITT
por: Schönborn, Linda, et al.
Publicado: (2022)

COVID-19 and VITT: same or different?
por: Arepally, Gowthami M.
Publicado: (2021)

Cooling down VITT with IVIG
por: Lentz, Steven R.
Publicado: (2021)

Understanding VITT(ual) reality
por: Rauova, Lubica, et al.
Publicado: (2021)

Heparin‐induced thrombocytopenia in end‐stage renal disease: Reliability of the PF4‐heparin ELISA
por: Kelly, Julie, et al.
Publicado: (2021)

‘Beta-interferons’ and ‘oligoclonal bands’ in multiple sclerosis in India
por: Hassan, K. M.
Publicado: (2011)

COVID-19 vaccin et VITT
por: Pernod, G.
Publicado: (2021)

ViTT: Vision Transformer Tracker
por: Zhu, Xiaoning, et al.
Publicado: (2021)

Second-dose VITT: rare but real
por: Pavord, Sue, et al.
Publicado: (2022)

Long VITT: A case report
por: Roberge, Guillaume, et al.
Publicado: (2023)

Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia
por: Prechel, M Margaret, et al.
Publicado: (2013)

Current Perspectives on Diagnostic Assays and Anti-PF4 Antibodies for the Diagnosis of Heparin-Induced Thrombocytopenia
por: Sahu, Kamal K, et al.
Publicado: (2020)

Vaccination-induced thrombocytopenia and thrombosis (VITT) and pre-VITT: Do not miss (or misdiagnose) the new member of the thrombotic thrombocytopenias family
por: Noyé, Mickaël, et al.
Publicado: (2022)

Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Gabarin, Nadia, et al.
Publicado: (2022)

Decline in Pathogenic Antibodies over Time in VITT
por: Schönborn, Linda, et al.
Publicado: (2021)

VITT and Second Doses of Covid-19 Vaccine
por: Lacy, Joanne, et al.
Publicado: (2021)

Vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Warkentin, Theodore E.
Publicado: (2022)

Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)
por: Makris, Michael, et al.
Publicado: (2021)

VITT(al) insights into vaccine-related clots
por: Strich, Jeffrey R., et al.
Publicado: (2021)

Understanding vaccine‐induced thrombotic thrombocytopenia (VITT)
por: Dix, Caroline, et al.
Publicado: (2022)

Oligoclonality of human intestinal intraepithelial T cells
Publicado: (1992)

Spontane intrakranielle Hypotension mit „brain sagging“ und reversibler frontotemporaler Demenz: Fallbericht und Übersicht über die Literatur
por: Hagemann, C., et al.
Publicado: (2022)

Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL
por: Brazdilova, K, et al.
Publicado: (2018)

Oligoclonal immunoglobulin repertoire in biliary remnants of biliary atresia
por: Taylor, Sarah A., et al.
Publicado: (2019)

Antiplatelet drugs block platelet activation by VITT patient serum
por: Smith, Christopher W., et al.
Publicado: (2021)

Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Greinacher, Andreas, et al.
Publicado: (2022)

Syndrome VITT : le vaccin Janssen également concerné ?
por: Manus, Jean-Marie
Publicado: (2021)

COVID-19 vaccine-induced VITT/TSS in Malaysia
Publicado: (2022)

Vaccine-induced thrombosis and thrombocytopenia (VITT); Exploring the unknown
por: Sunder, Ashok, et al.
Publicado: (2022)

Prospective Identification of Oligoclonal/Abnormal Band of the Same Immunoglobulin Type as the Malignant Clone by Differential Location of M-Spike and Oligoclonal Band
por: Vyas, Shikhar G., et al.
Publicado: (2017)

Vaccine-induced thrombosis and thrombocytopenia (VITT) in Ireland: A review of cases and current practices
por: Swan, D., et al.
Publicado: (2021)

Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S
por: Huynh, Angela, et al.
Publicado: (2022)

Oligoclonal Expansions of CD8(+) T Cells in Chronic HIV Infection Are Antigen Specific
por: Wilson, Jamie D.K., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_mgk96i3js4p1v3dulrert955hm